![](https://www.diabetesnews.com/wp-content/uploads/2012/09/Expiry-drugs1-150x150.jpg)
Novo Nordisk’s oral insulin successfully completed an early-stage study bringing what would be the first product of its kind a step closer to market.
Read more
Novo Nordisk’s oral insulin successfully completed an early-stage study bringing what would be the first product of its kind a step closer to market.
Read more